American Heart Journal
Volume 157, Issue 5 , Page e41 , May 2009

Response to letter to the editor by Kovacic et al

References 

  1. Kovacic JC, Macdonald P, Feneley MP, et al. Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor and an intracoronary CD133+ cell infusion in patients with chronic refractory ischemic heart disease: the GAIN I trial. Am Heart J. 2008;156:955–964
  2. Henry TD, Satran D, Wilson RF. Phase I cardiovascular cell therapy clinical trials: are we running with scissors?. Am Heart J. 2008;156:808–809
  3. Losordo DW, Schatz RA, White CJ, et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind randomized controlled trial. Circulation. 2007;115:3165–3172
  4. Kang HJ, Kim HS, Zhang SY, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilized with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomized clinical trial. Lancet. 2004;363:751–756

PII: S0002-8703(09)00136-7

doi: 10.1016/j.ahj.2009.02.010

American Heart Journal
Volume 157, Issue 5 , Page e41 , May 2009

Article Tools